Skip to content

Effect of Clomiphene Citrate on Uterine Blood Fow in Women With Unexplained Delayed Conception

Effect of Clomiphene Citrate on Uterine Hemodynamics in Women With Unexplained Infertility

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03322852
Enrollment
50
Registered
2017-10-26
Start date
2014-10-01
Completion date
2016-10-30
Last updated
2017-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

In a prospective observational study at a university teaching hospital, blood flow indices and serum hormone levels were compared between spontaneous and stimulated cycles in the same group of 50 patients with unexplained delayed conception.

Detailed description

In a prospective observational study at a university teaching hospital, the mid-luteal (peri-implantation) endometrial thickness and volume, uterine artery pulsatility index (PI) and resistance index (RI), endometrial and subendometrial vascularization index, flow index, and vascularization flow index, and serum estradiol and progesterone levels were compared between spontaneous and clomiphene citrate stimulated cycles in the same group of 50 patients with unexplained infertility.

Interventions

OTHERVascularization indices observation

The mid-luteal endometrial thickness and volume, uterine vascularization indices of uterine artery pulsatility index and resistance index, endometrial and subendometrial vascularization index, flow index, and vascularization flow index, and serum estradiol and progesterone levels were calculated in spontaneous then stimulated cycles in the same group of infertile patients

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Unexplained infertility * Body mass index less than 30 * Regular menstruation * Normal pelvic examination and ultrasonography

Exclusion criteria

* History of pelvic operations including cesarean section * History of pelvic inflammatory disease * Endometriosis * Pelvic pathology including uterine fibroids * General disease or medication that could potentially affect pelvic blood flow * Smoking

Design outcomes

Primary

MeasureTime frameDescription
Flow index of the endometrial regionDay 22 to 24 of the menstrual cycleFlow index of the endometrial region was measured by a researcher

Secondary

MeasureTime frameDescription
Vascularization index of the endometrial regionDay 22 to 24 of the menstrual cycleVascularization index of the endometrial region was measured by a researcher
Vascularization flow index of the endometrial regionDay 22 to 24 of the menstrual cycleVascularization flow index of the endometrial region was measured by a researcher
Vascularization flow index of the sub-endometrial regionDay 22 to 24 of the menstrual cycleVascularization flow index of the sub-endometrial region was measured by a researcher
Flow index of the sub-endometrial regionDay 22 to 24 of the menstrual cycleFlow index of the sub-endometrial region was measured by a researcher
Vascularization index of the sub-endometrial regionDay 22 to 24 of the menstrual cycleVascularization index of the sub-endometrial region was measured by a researcher

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026